E. Ohman J or Asset Management AB Has $12.66 Million Position in Intuitive Surgical, Inc. $ISRG

E. Ohman J or Asset Management AB raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 28,306 shares of the medical equipment provider’s stock after buying an additional 1,123 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Intuitive Surgical were worth $12,659,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Tobam raised its holdings in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical in the second quarter valued at about $27,000. 1248 Management LLC acquired a new position in Intuitive Surgical in the 1st quarter worth about $30,000. Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $30,000. Finally, Riggs Asset Managment Co. Inc. lifted its holdings in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of research reports. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. HSBC increased their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn lifted their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Piper Sandler upped their price objective on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Finally, Wells Fargo & Company raised their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $611.08.

Insider Buying and Selling

In other news, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 4,500 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $496,455.52. The trade was a 83.23% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $577.81 on Friday. The company has a market capitalization of $207.13 billion, a PE ratio of 76.43, a price-to-earnings-growth ratio of 5.28 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company’s fifty day moving average price is $555.54 and its 200 day moving average price is $507.11.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period last year, the business posted $1.84 earnings per share. The firm’s revenue was up 22.9% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.